Tag: Clinical Development Plan

August 3, 2017

Oncolytics Biotech Posts Q2 Financials

Oncolytics Biotech revealed their financial results for the second quarter of 2017.
July 31, 2017

uniQure Reacquires Rights for Gene Therapy Candidate

uniQure N.V. entered an agreement with Chiesi Group to reacquire the rights to co-develop and commercialize its hemophilia B gene...
May 18, 2017

Oncolytics Biotech will Present Abstracts from Studies

Oncolytics Biotech revealed the publication of new data from two new studies, set to be presented at the upcoming American...
May 8, 2017

Oncolytics' Reolysin Gets Fast Track Designation from FDA

Oncolytics Biotech announced the US Food and Drug Administration granted a fast track designation for Reolysin, an immuno-oncology viral agent...
May 5, 2017

Oncolytics Posts Financial Report for Q1 2017

Oncolytics Biotech released their financial results for the first quarter of 2017.
April 12, 2017

Oncolytics Gives Details on Plan for REOLYSIN

Oncolytics Biotech announced its initial registration pathway and clinical development plan for REOLYSIN, their immuno-oncology viral agent.